Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ARGXargenx SE	REGNRegeneron Pharmaceuticals	ONCBeOne Medicines AG
Snapshot
Price	$918.25	$736.02	$354.45
Market cap	$55.53B	$68.59B	$33.43B
Valuation
P/E	26x	17.4x	71.9x
Forward P/E	18.6x	16.7x	—
Growth
Revenue growth	80.6%	5.9%	36.2%
EPS growth	111.4%	4.4%	—
Profitability
Net margin	48.2%	29.6%	7.8%
ROE	22.9%	14.3%	5.2%
Balance sheet & cash
Debt / equity	0.01x	0.09x	0.25x
Free cash flow yield	—	6.3%	—
Dividend yield	—	0.6%	—
Verdict
Investment rating	Strong· 88	Favorable· 69	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ARGXtoday $918	REGNtoday $736	ONCtoday $354
2027	$1,456.02 – $2,135.50+133% CAGR	$576.30 – $845.25+15% CAGR	$362.02 – $530.96+50% CAGR
2028	$3,078.32 – $4,514.88+122% CAGR	$601.66 – $882.44+9% CAGR	$493.00 – $723.06+43% CAGR
2029	$6,508.19 – $9,545.35+118% CAGR	$628.13 – $921.26+8% CAGR	$671.36 – $984.66+41% CAGR
2030	$13,759.62 – $20,180.78+117% CAGR	$655.77 – $961.80+7% CAGR	$914.26 – $1,340.91+39% CAGR
2031	$29,090.59 – $42,666.20+115% CAGR	$684.63 – $1,004.12+6% CAGR	$1,245.04 – $1,826.06+39% CAGR
5-yr CAGR	99.6% – 115.5%	-1.4% – 6.4%	28.6% – 38.8%